12 Best Low Price Pharma Stocks To Invest In Right Now

8. Alvotech (NASDAQ:ALVO)

Share Price as of the Close of February 21: $12.28

Alvotech (NASDAQ:ALVO) is a biopharmaceutical company specializing in biosimilars—affordable alternatives to expensive biologic medicines. It focuses on developing monoclonal antibodies and complex biologics for diseases like cancer, autoimmune disorders, and eye conditions.

Alvotech (NASDAQ:ALVO) reported strong growth in Q3 2024, with revenue reaching $339 million for the first nine months—a nearly ninefold increase from 2023. This surge was driven by higher product sales and milestone payments from development and regulatory achievements. Product revenue alone hit $128 million, a 330% YoY increase, with Q3 sales reaching a record $62 million, up 16% from Q2, positioning Alvotech (NASDAQ:ALVO) as one of the Best Low Price Pharma Stocks.

The company also turned profitable, reporting an operating profit of $56 million for the first nine months, a major improvement from a $278 million loss in 2023. Adjusted EBITDA flipped to positive at $87 million, compared to a negative $226 million last year. Product margins rose to 37% in Q3 from 17% in Q2, reflecting better cost management and pricing strategies.

Alvotech (NASDAQ:ALVO)’s success comes from its strong execution in bringing biosimilars to market. Growing product sales and milestone payments indicate increasing market acceptance and progress in regulatory approvals, positioning the company for continued growth.